Ikena Oncology
在场
高管
查看带有其 17 名主要高管的组织结构图
Ikena Oncology 搜索最多的简介
- Mark Manfredi, Director, President and Chief Executive Officer
- Owen Hughes, Chairman of the Board
- Jean-Francois Formela, Director
高管在Ikena Oncology变化
- Sergio Santillana, Chief Medical Officer, 已经离开公司 (新闻发布的2024二月22号).
- Caroline Germa已作为Chief Medical Officer加入公司 (新闻发布的2024二月22号).
创建提醒
跟踪 Ikena Oncology 的高管变动
生物技术
Ikena Oncology 拥有 2,316 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Ikena Oncology 的最新新闻稿
- Ikena Oncology to Participate in the William Blair Biotech Focus Conference 2022 | Ikena Oncology
- Ikena Oncology Receives FDA Fast Track Designation for Novel TEAD Inhibitor IK-930 to Treat Unresectable NF2-Deficient Mesothelioma | Ikena Oncology
- Ikena Oncology to Participate in Spring 2022 Investor Conferences | Ikena Oncology
- Ikena Oncology Reports First Quarter 2022 Financial Results and Provides a Corporate Update | Ikena Oncology
- Ikena Oncology and Vall d’Hebron Institute of Oncology Announce Research & Development Collaboration | Ikena Oncology
- Ikena Oncology to Present at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting | Ikena Oncology
- Ikena Oncology to Present Preclinical Findings on IK-930, a Novel TEAD Inhibitor at the 2022 American Association for Cancer Research (AACR) Annual Meeting | Ikena Oncology
- Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update | Ikena Oncology
- Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors | Ikena Oncology
- Ikena Oncology to Participate in Cowen 42nd Annual Health Care Conference | Ikena Oncology
- View more press releases Close
关于 Ikena Oncology 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Mark Manfredi 
